120 related articles for article (PubMed ID: 27011226)
21. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
[TBL] [Abstract][Full Text] [Related]
22. Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma.
Choi YB; Bae GE; Lee NH; Kim JS; Lee SH; Yoo KH; Sung KW; Koo HH
J Korean Med Sci; 2015 Aug; 30(8):1062-7. PubMed ID: 26240483
[TBL] [Abstract][Full Text] [Related]
23. Autologous bone marrow transplantation for very bad prognosis neuroblastoma.
Philip T; Biron P; Philip I; Favrot M; Bernard JL; Zucker JM; Lutz B; Plouvier E; Rebattu P; Carton M
Prog Clin Biol Res; 1985; 175():569-86. PubMed ID: 3887433
[No Abstract] [Full Text] [Related]
24. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.
Ladenstein R; Philip T; Lasset C; Hartmann O; Garaventa A; Pinkerton R; Michon J; Pritchard J; Klingebiel T; Kremens B; Pearson A; Coze C; Paolucci P; Frappaz D; Gadner H; Chauvin F
J Clin Oncol; 1998 Mar; 16(3):953-65. PubMed ID: 9508178
[TBL] [Abstract][Full Text] [Related]
25. Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma.
Sung KW; Lee SH; Yoo KH; Jung HL; Cho EJ; Koo HH; Lee SK; Kim J; Lim DH; Suh YL; Kim DW
Bone Marrow Transplant; 2007 Jul; 40(1):37-45. PubMed ID: 17468771
[TBL] [Abstract][Full Text] [Related]
26. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
Sung KW; Son MH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ; Lee SK; Choi YS; Lim DH; Kim JS; Kim DW
Bone Marrow Transplant; 2013 Jan; 48(1):68-73. PubMed ID: 22635247
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
Matthay KK; Perez C; Seeger RC; Brodeur GM; Shimada H; Atkinson JB; Black CT; Gerbing R; Haase GM; Stram DO; Swift P; Lukens JN
J Clin Oncol; 1998 Apr; 16(4):1256-64. PubMed ID: 9552023
[TBL] [Abstract][Full Text] [Related]
28. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
[TBL] [Abstract][Full Text] [Related]
29. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
[TBL] [Abstract][Full Text] [Related]
30. [High-dose chemoradiotherapy with bone marrow transplantation as a consolidation treatment of neuroblastoma. Results in 49 unselected patients with stage IV cancer and older than 1 year. Report of the LMCE neuroblastoma group].
Kremens B; Philip T; Bernard JL; Zucker JM
Klin Padiatr; 1987; 199(3):218-23. PubMed ID: 3306132
[TBL] [Abstract][Full Text] [Related]
31. [Intensive chemotherapy and bone marrow grafting during the consolidation phase of stage IV neuroblastoma].
Philip T; Zucker JM; Bernard JL; Bordigoni P; Souillet G; Robert A; Roche H; Philip I; Chauvin F; Favrot MC
Bull Cancer; 1988; 75(1):113-7. PubMed ID: 3282573
[TBL] [Abstract][Full Text] [Related]
32. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk neuroblastoma patients.
Molina B; Alonso L; Gonzalez-Vicent M; Andion M; Hernandez C; Lassaletta A; Cormenzana M; Lopez-Ibor B; Villa M; Molina J; Diaz MA
Pediatr Hematol Oncol; 2011 Mar; 28(2):115-23. PubMed ID: 21299340
[TBL] [Abstract][Full Text] [Related]
33. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.
Matthay KK; Atkinson JB; Stram DO; Selch M; Reynolds CP; Seeger RC
J Clin Oncol; 1993 Nov; 11(11):2226-33. PubMed ID: 8229138
[TBL] [Abstract][Full Text] [Related]
34. Minimal residual disease is a prognostic marker for neuroblastoma with bone marrow infiltration.
Cai JY; Pan C; Tang YJ; Chen J; Ye QD; Zhou M; Xue H; Tang JY
Am J Clin Oncol; 2012 Jun; 35(3):275-8. PubMed ID: 21537148
[TBL] [Abstract][Full Text] [Related]
35. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
Cheung NK; Guo HF; Heller G; Cheung IY
Clin Cancer Res; 2000 Jul; 6(7):2653-60. PubMed ID: 10914706
[TBL] [Abstract][Full Text] [Related]
36. Neuroblastoma: issues in transplantation.
Grupp SA; Asgharzadeh S; Yanik GA
Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S92-100. PubMed ID: 22226119
[No Abstract] [Full Text] [Related]
37. A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy.
Kohler JA; Imeson J; Ellershaw C; Lie SO
Br J Cancer; 2000 Nov; 83(9):1124-7. PubMed ID: 11027423
[TBL] [Abstract][Full Text] [Related]
38. In vivo purging of bone marrow in children with poor-risk neuroblastoma for marrow collection and autologous bone marrow transplantation.
Saarinen UM; Wikström S; Mäkipernaa A; Lanning M; Perkkiö M; Hovi L; Rapola J; Sariola H
J Clin Oncol; 1996 Oct; 14(10):2791-802. PubMed ID: 8874341
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
Hero B; Hunneman DH; Gahr M; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):220-3. PubMed ID: 11464889
[TBL] [Abstract][Full Text] [Related]
40. Neuroblastoma today.
Ferster A; Schots R; Maurus R; Otten J
Biomed Pharmacother; 1988; 42(4):247-55. PubMed ID: 3056532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
